Markus Gerhard
Overview
Explore the profile of Markus Gerhard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
3599
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holle J, Reitmeir R, Behrens F, Singh D, Schindler D, Potapenko O, et al.
Am J Transplant
. 2025 Feb;
PMID: 39978595
Kidney transplantation (KT) is the best treatment for end-stage kidney disease, with graft survival critically affected by the recipient's immune response. The role of the gut microbiome in modulating this...
2.
Ben Khaled N, Schulz C, Alunni-Fabbroni M, Bronny K, Jochheim L, Kalali B, et al.
Digestion
. 2025 Feb;
:1-11.
PMID: 39970893
Introduction: Immunomodulating effects of Helicobacter pylori (H. pylori) have been shown to inhibit antitumor immunity. Resistance to immune checkpoint inhibitor (ICI)-based therapies is common among patients with hepatocellular carcinoma (HCC)....
3.
Pan K, Li W, Zhang L, Liu W, Ma J, Zhang Y, et al.
Nat Med
. 2024 Jul;
30(11):3250-3260.
PMID: 39079993
Gastric cancer is a leading cause of cancer-related deaths in China. Affecting more than 40% of the world's population, Helicobacter pylori is a major risk factor for gastric cancer. While...
4.
Engelsberger V, Gerhard M, Mejias-Luque R
Front Cell Infect Microbiol
. 2024 Feb;
14:1339750.
PMID: 38343887
Infecting about half of the world´s population, is one of the most prevalent bacterial infections worldwide and the strongest known risk factor for gastric cancer. Although colonizes exclusively the gastric...
5.
Fuchs S, Gong R, Gerhard M, Mejias-Luque R
Curr Top Microbiol Immunol
. 2024 Jan;
444:83-115.
PMID: 38231216
Helicobacter pylori is a prevalent pathogen, which affects more than 40% of the global population. It colonizes the human stomach and persists in its host for several decades or even...
6.
Luo S, Ru J, Khan Mirzaei M, Xue J, Peng X, Ralser A, et al.
Gut
. 2023 Nov;
73(9):1592-1595.
PMID: 37918887
No abstract available.
7.
Fan X, Zhang Y, Wang P, Song Q, Wang M, Mejias-Luque R, et al.
Int J Cancer
. 2023 Oct;
154(6):1111-1123.
PMID: 37842828
Effective screening and early detection are critical to improve the prognosis of gastric cancer (GC). Our study aims to explore noninvasive multianalytical biomarkers and construct integrative models for preliminary risk...
8.
Li Z, Bronny K, Formichella L, Mejias-Luque R, Burrell T, Macke L, et al.
Clin Microbiol Infect
. 2023 Oct;
30(1):114-121.
PMID: 37827383
Objectives: Early diagnosis is important in controlling Helicobacter pylori-induced gastritis and progression to gastric malignancy. Serological testing is an efficient non-invasive diagnostic method, but currently does not allow differentiation between...
9.
Luo S, Ru J, Khan Mirzaei M, Xue J, Peng X, Ralser A, et al.
Gut Microbes
. 2023 Sep;
15(2):2257291.
PMID: 37747149
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. While a close correlation between chronic infection and CRC has been reported, the role of the virome has...
10.
Baskerville M, Kovalyova Y, Mejias-Luque R, Gerhard M, Hatzios S
PLoS Pathog
. 2023 Jul;
19(7):e1011526.
PMID: 37494402
Mammalian cells synthesize the antioxidant glutathione (GSH) to shield cellular biomolecules from oxidative damage. Certain bacteria, including the gastric pathogen Helicobacter pylori, can perturb host GSH homeostasis. H. pylori infection...